Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration | PLOS ONE
For the FITs | Antiplatelet Therapy For High Bleeding Risk Patients Undergoing PCI - American College of Cardiology
Benefits from short-term vs standard DAPT (dual antiplatelet therapy)... | Download Scientific Diagram
Long-term Dual Antiplatelet Therapy Benefits Reinforced in SCAI Late-breaking Study | DAIC
Shortened dual antiplatelet therapy in contemporary percutaneous coronary intervention era
SYNERGY™ Clinical Program - Short DAPT - Boston Scientific
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting - ScienceDirect
Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration | PLOS ONE
EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent | tctmd.com
Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials - Atherosclerosis
Short DAPT Followed by Clopidogrel monotherapy No Better Than Long term DAPT: JAMA
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation | JACC: Cardiovascular Interventions
Dual antiplatelet therapy after percutaneous coronary intervention: entering the final chapter? - EuroIntervention
Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting - ScienceDirect
Shorter DAPT With Xience Stent is Noninferior to Standard DAPT | DAIC
Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent -